eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
2/2018
vol. 22
 
Share:
Share:
more
 
 
abstract:
Short communication

Identification of catheter misplacement in early port CVC dysfunction

Davide Mauri, Georgia Zafeiri, Lampriani Tsali, Anastasia Chalkidou, Georgios Zarkavelis, Alexandra Papadaki, Panagiotis Filis, George Pentheroudakis

Contemp Oncol (Pozn) 2018; 22 (2): 129-134
Online publish date: 2018/06/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The use of port central venous catheters (CVCs) for chemotherapeutical use has seen exponential growth over the last decades. However, port CVC misplacement may lead to catheter malfunction (such as partial or total catheter blockade), which might be complicated by thrombosis and catheter superinfections, and these in turn may lead to pulmonary embolism and bloodstream infections. The overall occurrence of port CVC misplacement is up to 6%; nonetheless, port CVC misplacement may occur in up to 67% of patients with early CVC dysfunction (occurring within three months of catheter insertion). Thereafter, the prompt evaluation of catheter position among patients with first-trimester CVC dysfunction is extremely important. The aim of the present manuscript is to support medical oncologists, haematologists, and clinicians in timely suspicion and recognition of port CVC misplacement among patients with early CVC dysfunction. Radiological educational iconographic materials that will assist a prompt estimate of port-CVC dislocation are provided.
keywords:

central venous catheters, port, chemotherapy, CVCs, dysfunction, misplacement

references:
Sousa B, Furlanetto J, Hutka M, Gouveia P, Wuerstlein R, Mariz JM, Pinto D, Cardoso F; ESMO Guidelines Committee. Central venous accesss in Oncology: ESMO Clinical Practice Guidelines. Ann Oncol 2015; 26 (Suppl. 5): 152-168.
Schiffer CA, Mangou PB, Wade JC et al. Central Venous Catheter care for the patient with cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2013; 17: 1357-1370.
Granic M, Zdravkovic D, Krstajic S, et al. Totally implantable central venous catheters of the port-a-cath type: complications due to its use in the treatment of cancer patients. J BUON 2014; 19: 842-846.
Mauri D, Roumbkou S, Michalopoulou S, Tsali L, et al. Port central venous catheters associated bloodstream infection during outpatient-based chemotherapy. Med Oncol 2010; 27: 1309-1313.
Wiegering V, Schmid S, Andres O, et al. Thrombosis as a complication of central venous access in pediatric patients with malignancies: a 5-year single-center experience. BMC Hematol 2014; 14: 18.
Bansal A, Binkert C, Robinson MK, Shulman LN, Pellerin L, Davison B. Impact of quality management monitoring and intervention on central venous catheter dysfunction in the outpatient chemotherapy infusion setting. J Vasc Interv Radiol 2008; 19: 1171-1175.
Kim HJ, Yun J, Kim HJ, et al. Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study. J Korean Med Sci 2010; 25: 1748-1753.
Pollo V, Dionízio D, Bucuvic EM, Castro JH, Ponce D. Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial. Hemodial Int 2016; 20: 378-384.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe